EE563 Evaluating the Cost-Utility of Intravesical Bacillus Calmette-Guérin Versus Radical Cystectomy in Patients With High-Risk Non-Muscle-Invasive Bladder Cancer in the UK
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.804
https://www.valueinhealthjournal.com/article/S1098-3015(22)03008-X/fulltext
Title :
EE563 Evaluating the Cost-Utility of Intravesical Bacillus Calmette-Guérin Versus Radical Cystectomy in Patients With High-Risk Non-Muscle-Invasive Bladder Cancer in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03008-X&doi=10.1016/j.jval.2022.09.804
First page :
Section Title :
Open access? :
No
Section Order :
10344